Every Hayes clinical evidence report is developed by experienced teams that have been trusted by healthcare decision makers since 1989. Here is a sampling of our content that is being used every day to inform defensible, evidence-based decisions by payers and providers.
Not all reports are available for public preview. For more information, please contact us.
The WiSE CRT system is a wireless left ventricular pacing system that works with an implanted right ventricular pacemaker and/or defibrillator for patients in whom cardiac resynchronization therapy (CRT) is indicated.
Humacyl is an off-the-shelf bioengineered human acellular vessel proposed for use in the repair of vascular trauma. This technology uses a process to decellularize donated human vascular smooth muscle cells, while preserving extracellular matrix proteins. This results in a tubular scaffold that is acellular at the time of implantation and becomes populated with the patient’s …
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of cooled radiofrequency ablation (CRFA) using the Coolief system (Avanos Medical Inc.) for relief of pain and improvement of function in adults with degenerative hip disease.
Focus of the Report: The focus of this Health Technology Assessment is to evaluate the effectiveness and safety of the minimally invasive lumbar decompression (mild) procedure, an approach that uses a proprietary surgical kit (mild; Vertos Medical Inc.) to treat lumbar spinal stenosis (LSS) in adult (≥ 18 years old) patients.
read more
Tofersen is an investigational antisense oligonucleotide proposed for the treatment of amyotrophic lateral sclerosis (ALS) caused by mutations in the SOD1 gene.
Tofersen is an investigational antisense oligonucleotide proposed for the treatment of amyotrophic lateral sclerosis (ALS) caused by mutations in the SOD1 gene.
Botaretigene sparoparvovec is an investigational gene replacement therapy for the treatment of X-linked retinitis pigmentosa due to mutations in the RPGR gene. It is administered by subretinal injection.
Donanemab is an investigational, intravenously administered amyloid beta-directed antibody proposed for the treatment of Alzheimer disease.
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of laser interstitial thermal therapy (LITT), also known as stereotactic laser ablation (SLA), for the treatment of brain radiation necrosis (RN).
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of EndeavorRx (Akili Interactive Labs Inc.) to improve attention function in children with attention-deficit/hyperactivity disorder (ADHD).